Voglolysis 0.3mg Tablet
Marketer
Jrb Lifesciences Private Limited
Salt Composition
Voglibose (0.3mg)
Overview Voglolysis 0.3mg Tablet
Glimepiride 0.3mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated blood glucose following meals, particularly when dietary adjustments and other similar treatments prove insufficient. Take Glimepiride 0.3mg immediately before eating; dosage and frequency are determined by your physician to optimize blood sugar control. Never discontinue this medication abruptly without consulting your doctor; doing so may elevate blood sugar, potentially causing serious complications such as renal impairment or vision loss. This medication forms part of a comprehensive diabetes management plan that must include a healthy diet, regular exercise, and weight management, as directed by your healthcare provider. Regular blood glucose monitoring is essential while using this medicine. Common side effects include abdominal discomfort, bloating, appetite changes, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Glimepiride alone rarely causes hypoglycemia, combining it with other diabetes medications (especially insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; ordinary table sugar may be ineffective. Inform your doctor of any liver or kidney conditions before commencing treatment. Do not use this medication if you have bowel inflammation or ulcers (e.g., Crohn's disease or ulcerative colitis). Pregnant or breastfeeding individuals must consult their physician prior to use. Disclose all other medications you are taking to ensure safe usage. Limit alcohol consumption as it can heighten the risk of hypoglycemia.
Uses of Voglolysis 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Voglolysis 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Voglolysis 0.3mg Tablet on an empty stomach.
Common Side effects of Voglolysis 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglolysis 0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglolysis 0.3mg Tablet on an empty stomach.
How Voglolysis 0.3mg Tablet works:
Voglolysis 0.3mg tablets are used to manage diabetes. Their mechanism of action involves blocking intestinal enzymes that digest complex carbohydrates, thus moderating postprandial glucose spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglolysis 0.3mg tablets with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Voglolysis 0.3mg tablets is generally deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, corresponding human data are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglolysis 0.3mg tablets without significant risk. Available human data indicates minimal danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglolysis 0.3mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Voglolysis 0.3mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglolysis 0.3mg tablets cautiously, as dose modification may be necessary. Physician consultation is recommended.
What if you forget to take Voglolysis 0.3mg Tablet :
Omit any missed Voglolysis 0.3mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglolysis 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
3,018 People bought this recently